SCHEMBL3674559

SCHEMBL3674559

CC(O)C=CC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13840523 1.00
SCHEMBL3674557 1.00
SCHEMBL8471281 1.00
SCHEMBL5868370 0.79 ALDH1A1 (0.39)
SCHEMBL5868371 0.79 ALDH1A1 (0.39)
SCHEMBL1783898 0.77
SCHEMBL1783896 0.77
SCHEMBL9254533 0.73
SCHEMBL9261865 0.73
SCHEMBL9014125 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1755679-A2 KIT FOR TREATMENT OF CANCER Redoxia Israel Limited (IL) 2007-02-28 EP claimed
WO-2005107370-A2 KIT FOR TREATMENT OF CANCER REDOXIA ISRAEL LTD (IL) 2005-11-17 WO claimed
EP-0312412-B1 NORBORNANE DERIVATIVES, METHOD FOR THEIR PREPARATION AND COSMETIC AND MEDICINAL COMPOSITIONS CONTAINING THEM L'OREAL (FR) 1991-06-26 EP claimed
EP-0312412-A1 Norbornane derivatives, method for their preparation and cosmetic and medicinal compositions containing them L'OREAL (FR) 1989-04-19 EP claimed
CN-116273177-A Supported resin catalyst and preparation method and application thereof 安徽皖东树脂科技有限公司 2023-06-23 CN disclosed
US-20210161847-A1 METHOD OF TREATMENT FOR REDUCING PAIN SENSITIZATION OTT DAVID MICHAEL (US) 2021-06-03 US disclosed
US-10940129-B2 Method of treatment for reducing pain sensitization OTT DAVID MICHAEL (US) 2021-03-09 US disclosed
US-20200061008-A1 METHOD OF TREATMENT FOR REDUCING PAIN SENSITIZATION OTT DAVID MICHAEL (US) 2020-02-27 US disclosed
WO-2019174063-A1 CHEMICAL REACTION APPARATUS AND APPLICATION THEREOF 安丽华 2019-09-19 WO disclosed
US-7858659-B2 Redox therapy for tumors HOFFMAN ARNOLD 2010-12-28 US disclosed
US-20080287541-A1 Kit for Treatment of Cancer REDOXIA ISRAEL LTD. (IL) 2008-11-20 US disclosed
US-7189512-B2 Methods for variation detection Porat, Noga (IL) 2007-03-13 US disclosed
EP-1394251-A1 Method for the selective randomization of polynucleotides Direvo Biotech AG (DE) 2004-03-03 EP disclosed
US-20040023220-A1 Integrated method for PCR cleanup and oligonucleotide removal APPLIED BIOSYSTEMS, LLC 2004-02-05 US disclosed
US-20040018987-A1 Redox therapy for tumors HOFFMAN ARNOLD (IL) 2004-01-29 US disclosed
WO-2004009851-A2 METHOD FOR PCR CLEANUP AND OLIGONUCLEOTIDE REMOVAL APPLERA CORPORATION (US) 2004-01-29 WO disclosed
US-5047575-A Norbornene carboxylic acids and esters L'OREAL (FR) 1991-09-10 US disclosed
EP-0312412-B1 NORBORNANE DERIVATIVES, METHOD FOR THEIR PREPARATION AND COSMETIC AND MEDICINAL COMPOSITIONS CONTAINING THEM L'OREAL (FR) 1991-06-26 EP disclosed
EP-0312412-A1 Norbornane derivatives, method for their preparation and cosmetic and medicinal compositions containing them L'OREAL (FR) 1989-04-19 EP disclosed
EP-0060659-A1 Pharmaceutical composition for tumour treatment and process for preparing it NATIONAL FOUNDATION FOR CANCER RESEARCH, INC. (US) 1982-09-22 EP disclosed